<DOC>
	<DOCNO>NCT00728364</DOCNO>
	<brief_summary>Anderson-Fabry disease rare X-linked lysosomal storage disorder due deficiency alfa-galactosidase A ( AGAL ) . The subsequent accumulation glycosphingolipids may lead cardiac , renal , central nervous system impairment well premature death . Recently publish study suggest true incidence disease may underestimate certain risk group , e.g . patient chronic kidney disease ( CKD ) . Therefore , investigator initiate multicenter case-finding study Austria screen patient chronic kidney disease yet renal replacement therapy . Molecular isoforms globotriaosylceramide ( Gb3 ) , characterize different chain lengths N-acyl residue , determine urine sample . Characteristic parameter , include ratio C24/C18 isoforms use identify patient liable disease . A positive result confirm biochemical genetic testing . A sample size 5.000 chronic kidney disease patient envisage allow detection 1 25 patient Anderson-Fabry disease .</brief_summary>
	<brief_title>Anderson-Fabry Disease Chronic Kidney Disease Patients Not Renal Replacement Therapy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>Chronic kidney disease KDOQI stage 15 Informed consent Patients already renal replacement therapy Not willing participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Anderson Fabry disease</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>prevalence</keyword>
</DOC>